Ethyl 4-[(2-hy­droxy­eth­yl)amino]-2-(4-meth­oxyphen­yl)-1-methyl-5-oxo-2,5-di­hydro-1H-pyrrole-3-carboxyl­ate

Fatin Nur Ain Abdul Rashid; Mohd Fazli Mohammat; Mohd Abdul Fatah Abdul Manan; Ayisy Amirul Afti Bakhtiar Afendy; David B Cordes; Aidan P McKay

doi:10.1107/S2414314624012227

. 2024 Dec 20;9(Pt 12):x241222. doi: 10.1107/S2414314624012227

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate

Fatin Nur Ain Abdul Rashid ^a, Mohd Fazli Mohammat ^a,^*, Mohd Abdul Fatah Abdul Manan ^b, Ayisy Amirul Afti Bakhtiar Afendy ^b, David B Cordes ^c, Aidan P McKay ^c

Editor: W T A Harrison^d

PMCID: PMC11701760 PMID: 39777006

In the title compound, the pyrrolidine and phenyl rings are almost perpendicular and an intramolecular N—H⋯O hydrogen bond occurs.

Keywords: crystal structure, oxopyrrolidine, racemic, hydrogen bond

Abstract

In the title compound, C₁₇H₂₂N₂O₅ the pyrrolidine ring is almost planar and subtends a dihedral angle of 85.77 (7)° with the pendant phenyl ring. An intramolecular N—H⋯O hydrogen bond generates an S(6) loop. In the crystal, the compound forms inversion dimers through O—H⋯O hydrogen bonds from the disordered hydroxyl group to either the hydroxyl or ester carbonyl O atom of the adjacent molecule.

Structure description

Molecules bearing a γ-lactam moiety are receiving attention from researchers since examples of these compounds have been shown to exhibit potential medicinal uses, for example to inhibit the proteasome in cancer therapy (Ōmura & Crump, 2019 ▸), or to act as a potent inhibitor against methicillin-resistant Staphylococcus aureus (Miranda et al., 2018 ▸; Wang et al., 2020 ▸; Chen et al., 2022 ▸). A facile method to prepare γ-lactams from readily available starting materials via one-pot multicomponent reactions has been reported in the literature (Metten et al., 2006 ▸): these versatile precursors contain numerous functionalities that can be modified and transformed to other useful intermediates. In our previous work, a γ-lactam precursor was subjected to a Leuckart-type reaction (Rashid et al., 2020 ▸) and herein we report the crystal structure of the title compound.

The title compound, C₁₇H₂₂N₂O₅, crystallizes in the monoclinic space group P2₁/n with one molecule in the asymmetric unit (Fig. 1 ▸). The five-membered pyrrolidine ring (C2–C5/N1) adopts a near planar conformation (r.m.s. deviation from planarity = 0.003 Å), with methoxybenzene, ethyl ester and hydroxyethyl amino substitutions at the 2, 3 and 4 ring positions, respectively. The dihedral angle between the pyrrolidine and phenyl rings is 85.77 (7)° and the N19—C20—C21—O22 torsion angle is −65.47 (16)°. The configuration of atom C2 in the asymmetric unit is R but crystal symmetry generates a racemic mixture. A weak intramolecular N19—H19⋯O15 hydrogen bond (Table 1 ▸) occurs, which closes an S(6) ring. A similar feature was observed in the structure of ethyl 1-(2-hydroxyethyl)-4-[(4-methoxyphenyl)amino]-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate (Abdul Rashid et al., 2023 ▸).

The molecular structure of the title compound, showing displacement ellipsoids drawn at the 50% probability level. Both orientations of the disordered hydroxyl hydrogen atom are shown.

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A	D—H	H⋯A	D⋯A	D—H⋯A
N19—H19⋯O15	0.92 (1)	2.19 (2)	2.8595 (15)	129 (2)
O22—H22A⋯O15ⁱ	0.98 (1)	2.08 (2)	3.0131 (16)	157 (4)
O22—H22B⋯O22ⁱ	0.98 (2)	1.83 (2)	2.796 (2)	167 (4)
C6—H6B⋯O22ⁱⁱ	0.98	2.57	3.4152 (18)	144
C8—H8⋯O13ⁱⁱⁱ	0.95	2.34	3.2556 (17)	162

Open in a new tab

Symmetry codes: (i) Inline graphic ; (ii) ; (iii) .

The terminal hydroxyl group of the hydroxyethyl amino moiety exhibits positional disorder of its hydrogen atom. Both positions correspond to intermolecular O—H⋯O hydrogen bonds to either the hydroxyl (O22) or ester carbonyl (O15) oxygen atom, of a neighbouring molecule thereby forming Inline graphic (11) rings that are either ‘anti-clockwise’ or ‘clockwise’ (Fig. 2 ▸). These dimers pack into the overall structure through a variety of weak C—H⋯O non-classical hydrogen bonds (Table 1 ▸).

View of the supramolecular dimers with both N—H⋯O intramolecular and O—H⋯O intermolecular hydrogen bonds. The disordered hydroxyl hydrogen atoms are shown in the ‘anti-clockwise’ conformation with the green dashed lines indicating the alternate ‘clockwise’ hydrogen-bonding scheme.

Synthesis and crystallization

The γ-lactam precursor, ethyl 4-hydroxy-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate was synthesized following the reported method for related compounds (Rashid et al., 2020 ▸). The title compound was prepared by adding ethanolamine (0.25 ml, 4.12 mmol) to a solution of the γ-lactam precursor (1.00 g, 3.43 mmol) and formic acid (0.21 ml, 5.49 mmol) in ethanol (25 ml) and allowed to reflux for 12 h. After completion of the reaction, the solution was removed in vacuo and the crude product was dissolved in ethyl acetate, which was washed with water. The combined organic layers were dried over anhydrous MgSO₄ before being concentrated under reduced pressure to yield a solid precipitate. Further washing of the precipitate with diethyl ether furnished the title compound as a dark-yellow solid (yield: 0.69 g, 60%). m.p. 89–90°C; IR (KBr, ν, cm⁻¹): 3478 (NH), 1692 (C=O), 1621 (C=C), 1242 (C—N); ¹H NMR (400 MHz, CDCl₃ -d₁) δ 7.03 (d, J = 8.7 Hz, 2H, CHAr), 6.80 (d, J = 8.7 Hz, 2H, CHAr), 4.87 (s, 1H, ArCHNCH₃), 4.10–3.90 (m, 4H, OCH₂ & CH₂OH), 3.76–3.74 (m, 5H, OCH₃ & NHCH₂), 2.70 (s, 3H, NCH₃), 1.01 (t, J = 7.1 Hz, 3H, CH₃); ¹³C NMR (100 MHz, CDCl₃ -d₁) δ 165.9 (C=O), 165.5 (C=O), 159.4 (quat. ArC), 147.6 (C—N), 129.0 (CHAr), 128.8 (quat. ArC), 113.8 (CHAr), 103.6 (CCO), 63.4 (CH₂OH), 63.2 (OCH₃), 59.5 (OCH₂), 55.3 (ArCHNCH₃), 44.6 (NHCH₂), 27.6 (NCH₃), 14.1 (CH₃); CHN: found C, 59.64; H, 6.54; N, 7.74 requires C, 61.07; H, 6.63; N, 8.38%; LCMS (ESI): calculated for C₁₇H₂₂N₂O₅ 357.1 [M + Na]⁺, found 357.1. Crystals suitable for X-ray diffraction were grown by slow evaporation of an ethyl acetate solution at room temperature.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. The N– and O-bound hydrogen atoms were located in a difference map and refined isotropically with distance restraints. The OH hydrogen atom was found to be disordered over two positions, its occupancy was fixed at 1/2, with U_eq riding on the parent atom.

Table 2. Experimental details.

Crystal data
Chemical formula	C₁₇H₂₂N₂O₅
M _r	334.36
Crystal system, space group	Monoclinic, P2₁/n
Temperature (K)	100
a, b, c (Å)	10.17216 (8), 9.24320 (6), 17.64603 (14)
β (°)	101.5111 (8)
V (Å³)	1625.77 (2)
Z	4
Radiation type	Cu Kα
μ (mm⁻¹)	0.84
Crystal size (mm)	0.09 × 0.07 × 0.01

Data collection
Diffractometer	Rigaku XtaLAB P200K
Absorption correction	Multi-scan (CrysAlis PRO; Rigaku OD, 2024 ▸)
T_min, T_max	0.735, 1.000
No. of measured, independent and observed [I > 2σ(I)] reflections	57922, 3336, 3074
R _int	0.071
(sin θ/λ)_max (Å⁻¹)	0.628

Refinement
R[F² > 2σ(F²)], wR(F²), S	0.040, 0.106, 1.06
No. of reflections	3336
No. of parameters	230
No. of restraints	3
H-atom treatment	H atoms treated by a mixture of independent and constrained refinement
Δρ_max, Δρ_min (e Å⁻³)	0.28, −0.27

Open in a new tab

Computer programs: CrysAlis PRO (Rigaku OD, 2024 ▸), SHELXT2018/2 (Sheldrick, 2015a ▸), SHELXL2019/3 (Sheldrick, 2015b ▸), Mercury (Macrae et al., 2020 ▸), OLEX2 (Dolomanov et al., 2009 ▸) and publCIF (Westrip, 2010 ▸).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2414314624012227/hb4500sup1.cif

x-09-x241222-sup1.cif^{(1.7MB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2414314624012227/hb4500Isup2.hkl

x-09-x241222-Isup2.hkl^{(266.4KB, hkl)}

x-09-x241222-Isup3.cml^{(6.2KB, cml)}

Supporting information file. DOI: 10.1107/S2414314624012227/hb4500Isup3.cml

CCDC reference: 2411088

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors acknowledge Universiti Teknologi MARA for financial support and the Centre of Chemical Synthesis & Polymer Technology (CCSPT), Institute of Science, Universiti Teknologi MARA Puncak Alam, Selangor, Malaysia for the provision of laboratory facilities.

full crystallographic data

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Crystal data

C₁₇H₂₂N₂O₅	F(000) = 712
M_r = 334.36	D_x = 1.366 Mg m⁻³
Monoclinic, P2₁/n	Cu Kα radiation, λ = 1.54184 Å
a = 10.17216 (8) Å	Cell parameters from 26738 reflections
b = 9.24320 (6) Å	θ = 4.6–75.3°
c = 17.64603 (14) Å	µ = 0.84 mm⁻¹
β = 101.5111 (8)°	T = 100 K
V = 1625.77 (2) Å³	Plate, colourless
Z = 4	0.09 × 0.07 × 0.01 mm

Open in a new tab

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Data collection

Rigaku XtaLAB P200K diffractometer	3336 independent reflections
Radiation source: Rotating Anode, Rigaku MM-007HF	3074 reflections with I > 2σ(I)
Rigaku Osmic Confocal Optical System monochromator	R_int = 0.071
Detector resolution: 5.8140 pixels mm^-1	θ_max = 75.6°, θ_min = 4.7°
shutterless scans	h = −12→12
Absorption correction: multi-scan (CrysAlisPro; Rigaku OD, 2024)	k = −11→11
T_min = 0.735, T_max = 1.000	l = −22→22
57922 measured reflections

Open in a new tab

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Refinement

Refinement on F²	Primary atom site location: dual
Least-squares matrix: full	Hydrogen site location: mixed
R[F² > 2σ(F²)] = 0.040	H atoms treated by a mixture of independent and constrained refinement
wR(F²) = 0.106	w = 1/[σ²(F_o²) + (0.0505P)² + 0.7868P] where P = (F_o² + 2F_c²)/3
S = 1.06	(Δ/σ)_max < 0.001
3336 reflections	Δρ_max = 0.28 e Å⁻³
230 parameters	Δρ_min = −0.27 e Å⁻³
3 restraints

Open in a new tab

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Refinement. Hydrogen atoms were placed in calculated positions except the on hydroxyl and amine groups (N19 and O22) which were located from F_map and refined subject to distance restraints and the U_eq of the hydroxyl hydrogens riding on O22. Hydrogens on O22 were observed in two distinct hydrogen bonding locations, both of which are modelled with occupancy fixed at 0.5 and H22B in part -1 as it was orientated towards a symmetry related H22B—O22.

Open in a new tab

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

	x	y	z	U_iso*/U_eq	Occ. (<1)
O5	0.34109 (10)	0.32829 (11)	0.29196 (6)	0.0283 (2)
O13	0.93989 (10)	0.92848 (11)	0.31984 (6)	0.0289 (2)
O15	0.80294 (10)	0.22664 (11)	0.49182 (6)	0.0316 (3)
O16	0.80905 (9)	0.46054 (10)	0.52944 (5)	0.0236 (2)
O22	0.40444 (12)	−0.06392 (13)	0.44164 (6)	0.0394 (3)
H22A	0.321 (2)	−0.096 (5)	0.457 (2)	0.059*	0.5
H22B	0.480 (4)	−0.017 (5)	0.477 (2)	0.059*	0.5
N1	0.45573 (11)	0.51525 (12)	0.36200 (7)	0.0223 (2)
N19	0.57207 (12)	0.15014 (12)	0.37782 (7)	0.0229 (3)
H19	0.6474 (15)	0.1133 (19)	0.4098 (10)	0.035 (5)*
C2	0.57805 (13)	0.54035 (14)	0.42004 (7)	0.0201 (3)
H2	0.553384	0.575074	0.469032	0.024*
C3	0.63422 (13)	0.38870 (14)	0.43190 (7)	0.0203 (3)
C4	0.55360 (13)	0.29314 (14)	0.38504 (7)	0.0202 (3)
C5	0.43611 (13)	0.37609 (15)	0.33929 (8)	0.0218 (3)
C6	0.36725 (14)	0.63225 (15)	0.32925 (9)	0.0273 (3)
H6A	0.410681	0.690047	0.294676	0.041*
H6B	0.348131	0.693750	0.370983	0.041*
H6C	0.283186	0.591964	0.299979	0.041*
C7	0.67047 (13)	0.64984 (14)	0.39345 (7)	0.0200 (3)
C8	0.70629 (14)	0.63505 (15)	0.32152 (8)	0.0247 (3)
H8	0.670204	0.557712	0.288350	0.030*
C9	0.79374 (14)	0.73181 (16)	0.29807 (8)	0.0266 (3)
H9	0.816202	0.721865	0.248590	0.032*
C10	0.84893 (13)	0.84382 (14)	0.34690 (8)	0.0226 (3)
C11	0.81191 (14)	0.86208 (14)	0.41785 (8)	0.0235 (3)
H11	0.847341	0.940002	0.450770	0.028*
C12	0.72214 (13)	0.76474 (14)	0.44028 (8)	0.0221 (3)
H12	0.695973	0.777571	0.488603	0.027*
C14	1.00316 (18)	1.03976 (19)	0.36932 (11)	0.0411 (4)
H14A	1.062776	1.095104	0.342862	0.062*
H14B	1.055617	0.996804	0.416585	0.062*
H14C	0.934820	1.104289	0.382711	0.062*
C15	0.75500 (13)	0.34857 (14)	0.48560 (7)	0.0212 (3)
C17	0.93178 (14)	0.43252 (15)	0.58571 (8)	0.0245 (3)
H17A	1.003709	0.398723	0.559586	0.029*
H17B	0.916399	0.357827	0.623200	0.029*
C18	0.96974 (15)	0.57457 (16)	0.62607 (8)	0.0301 (3)
H18A	0.982430	0.647720	0.587974	0.045*
H18B	1.053341	0.562775	0.664254	0.045*
H18C	0.898122	0.605610	0.652238	0.045*
C20	0.47715 (15)	0.04845 (15)	0.33305 (8)	0.0267 (3)
H20A	0.525209	−0.041922	0.325556	0.032*
H20B	0.441995	0.090415	0.281357	0.032*
C21	0.36072 (16)	0.01227 (17)	0.37099 (8)	0.0304 (3)
H21A	0.315223	0.102708	0.381347	0.036*
H21B	0.295103	−0.047698	0.335390	0.036*

Open in a new tab

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Atomic displacement parameters (Å²)

	U¹¹	U²²	U³³	U¹²	U¹³	U²³
O5	0.0270 (5)	0.0245 (5)	0.0287 (5)	−0.0031 (4)	−0.0058 (4)	0.0000 (4)
O13	0.0292 (5)	0.0295 (5)	0.0276 (5)	−0.0053 (4)	0.0047 (4)	0.0077 (4)
O15	0.0321 (6)	0.0207 (5)	0.0361 (6)	0.0034 (4)	−0.0076 (4)	−0.0020 (4)
O16	0.0247 (5)	0.0208 (5)	0.0222 (5)	−0.0009 (4)	−0.0028 (4)	0.0002 (4)
O22	0.0470 (7)	0.0409 (6)	0.0277 (6)	−0.0162 (5)	0.0015 (5)	0.0051 (5)
N1	0.0201 (5)	0.0198 (6)	0.0251 (6)	0.0000 (4)	0.0000 (4)	0.0006 (4)
N19	0.0243 (6)	0.0181 (5)	0.0240 (6)	−0.0011 (4)	−0.0007 (5)	0.0002 (4)
C2	0.0211 (6)	0.0192 (6)	0.0189 (6)	−0.0005 (5)	0.0015 (5)	−0.0004 (5)
C3	0.0228 (6)	0.0191 (6)	0.0189 (6)	−0.0016 (5)	0.0037 (5)	0.0007 (5)
C4	0.0219 (6)	0.0207 (6)	0.0180 (6)	−0.0015 (5)	0.0043 (5)	0.0019 (5)
C5	0.0224 (6)	0.0205 (6)	0.0220 (6)	−0.0010 (5)	0.0034 (5)	0.0019 (5)
C6	0.0244 (7)	0.0223 (7)	0.0327 (7)	0.0031 (5)	0.0000 (6)	0.0026 (6)
C7	0.0202 (6)	0.0184 (6)	0.0198 (6)	0.0018 (5)	0.0004 (5)	0.0018 (5)
C8	0.0293 (7)	0.0234 (7)	0.0202 (6)	−0.0025 (6)	0.0020 (5)	−0.0028 (5)
C9	0.0305 (7)	0.0307 (7)	0.0191 (6)	−0.0009 (6)	0.0059 (5)	0.0020 (5)
C10	0.0217 (6)	0.0208 (6)	0.0237 (6)	0.0010 (5)	0.0008 (5)	0.0075 (5)
C11	0.0259 (7)	0.0188 (6)	0.0237 (6)	−0.0016 (5)	0.0000 (5)	−0.0013 (5)
C12	0.0247 (7)	0.0211 (6)	0.0200 (6)	0.0006 (5)	0.0033 (5)	−0.0006 (5)
C14	0.0409 (9)	0.0382 (9)	0.0460 (9)	−0.0194 (7)	0.0129 (7)	−0.0030 (7)
C15	0.0235 (6)	0.0199 (6)	0.0203 (6)	−0.0035 (5)	0.0042 (5)	0.0012 (5)
C17	0.0222 (7)	0.0261 (7)	0.0224 (6)	−0.0003 (5)	−0.0020 (5)	0.0021 (5)
C18	0.0309 (8)	0.0290 (8)	0.0268 (7)	−0.0033 (6)	−0.0026 (6)	−0.0018 (6)
C20	0.0316 (7)	0.0222 (7)	0.0239 (7)	−0.0022 (6)	−0.0004 (6)	−0.0030 (5)
C21	0.0356 (8)	0.0259 (7)	0.0285 (7)	−0.0056 (6)	0.0037 (6)	−0.0017 (6)

Open in a new tab

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Geometric parameters (Å, º)

O5—C5	1.2267 (16)	C7—C8	1.3955 (19)
O13—C10	1.3684 (16)	C7—C12	1.3833 (18)
O13—C14	1.4178 (19)	C8—H8	0.9500
O15—C15	1.2242 (17)	C8—C9	1.382 (2)
O16—C15	1.3424 (16)	C9—H9	0.9500
O16—C17	1.4549 (15)	C9—C10	1.392 (2)
O22—H22A	0.983 (5)	C10—C11	1.3879 (19)
O22—H22B	0.983 (19)	C11—H11	0.9500
O22—C21	1.4236 (18)	C11—C12	1.3944 (19)
N1—C2	1.4636 (16)	C12—H12	0.9500
N1—C5	1.3502 (17)	C14—H14A	0.9800
N1—C6	1.4512 (17)	C14—H14B	0.9800
N19—H19	0.922 (14)	C14—H14C	0.9800
N19—C4	1.3447 (17)	C17—H17A	0.9900
N19—C20	1.4613 (17)	C17—H17B	0.9900
C2—H2	1.0000	C17—C18	1.507 (2)
C2—C3	1.5124 (18)	C18—H18A	0.9800
C2—C7	1.5180 (18)	C18—H18B	0.9800
C3—C4	1.3659 (18)	C18—H18C	0.9800
C3—C15	1.4423 (18)	C20—H20A	0.9900
C4—C5	1.5109 (18)	C20—H20B	0.9900
C6—H6A	0.9800	C20—C21	1.510 (2)
C6—H6B	0.9800	C21—H21A	0.9900
C6—H6C	0.9800	C21—H21B	0.9900

C10—O13—C14	117.09 (11)	O13—C10—C11	124.70 (12)
C15—O16—C17	116.94 (10)	C11—C10—C9	120.04 (12)
H22A—O22—H22B	125 (4)	C10—C11—H11	120.4
C21—O22—H22A	105 (3)	C10—C11—C12	119.25 (12)
C21—O22—H22B	114 (3)	C12—C11—H11	120.4
C5—N1—C2	114.42 (11)	C7—C12—C11	121.20 (12)
C5—N1—C6	123.27 (11)	C7—C12—H12	119.4
C6—N1—C2	122.25 (11)	C11—C12—H12	119.4
C4—N19—H19	114.8 (12)	O13—C14—H14A	109.5
C4—N19—C20	126.42 (12)	O13—C14—H14B	109.5
C20—N19—H19	118.2 (12)	O13—C14—H14C	109.5
N1—C2—H2	109.3	H14A—C14—H14B	109.5
N1—C2—C3	101.24 (10)	H14A—C14—H14C	109.5
N1—C2—C7	112.45 (10)	H14B—C14—H14C	109.5
C3—C2—H2	109.3	O15—C15—O16	123.23 (12)
C3—C2—C7	114.87 (11)	O15—C15—C3	124.58 (12)
C7—C2—H2	109.3	O16—C15—C3	112.19 (11)
C4—C3—C2	110.54 (11)	O16—C17—H17A	110.6
C4—C3—C15	124.14 (12)	O16—C17—H17B	110.6
C15—C3—C2	125.31 (11)	O16—C17—C18	105.76 (11)
N19—C4—C3	127.92 (13)	H17A—C17—H17B	108.7
N19—C4—C5	123.97 (12)	C18—C17—H17A	110.6
C3—C4—C5	108.10 (11)	C18—C17—H17B	110.6
O5—C5—N1	126.51 (13)	C17—C18—H18A	109.5
O5—C5—C4	127.79 (12)	C17—C18—H18B	109.5
N1—C5—C4	105.69 (11)	C17—C18—H18C	109.5
N1—C6—H6A	109.5	H18A—C18—H18B	109.5
N1—C6—H6B	109.5	H18A—C18—H18C	109.5
N1—C6—H6C	109.5	H18B—C18—H18C	109.5
H6A—C6—H6B	109.5	N19—C20—H20A	108.9
H6A—C6—H6C	109.5	N19—C20—H20B	108.9
H6B—C6—H6C	109.5	N19—C20—C21	113.26 (12)
C8—C7—C2	120.40 (12)	H20A—C20—H20B	107.7
C12—C7—C2	120.81 (11)	C21—C20—H20A	108.9
C12—C7—C8	118.79 (12)	C21—C20—H20B	108.9
C7—C8—H8	119.7	O22—C21—C20	111.24 (13)
C9—C8—C7	120.63 (13)	O22—C21—H21A	109.4
C9—C8—H8	119.7	O22—C21—H21B	109.4
C8—C9—H9	120.0	C20—C21—H21A	109.4
C8—C9—C10	120.03 (12)	C20—C21—H21B	109.4
C10—C9—H9	120.0	H21A—C21—H21B	108.0
O13—C10—C9	115.26 (12)

O13—C10—C11—C12	−177.32 (12)	C5—N1—C2—C7	122.29 (12)
N1—C2—C3—C4	0.97 (14)	C6—N1—C2—C3	−177.89 (12)
N1—C2—C3—C15	−178.34 (12)	C6—N1—C2—C7	−54.80 (16)
N1—C2—C7—C8	−50.65 (16)	C6—N1—C5—O5	−3.4 (2)
N1—C2—C7—C12	130.23 (13)	C6—N1—C5—C4	177.42 (12)
N19—C4—C5—O5	2.1 (2)	C7—C2—C3—C4	−120.45 (12)
N19—C4—C5—N1	−178.77 (12)	C7—C2—C3—C15	60.24 (17)
N19—C20—C21—O22	−65.47 (16)	C7—C8—C9—C10	1.2 (2)
C2—N1—C5—O5	179.51 (13)	C8—C7—C12—C11	−2.1 (2)
C2—N1—C5—C4	0.36 (15)	C8—C9—C10—O13	176.51 (12)
C2—C3—C4—N19	178.21 (13)	C8—C9—C10—C11	−2.7 (2)
C2—C3—C4—C5	−0.81 (14)	C9—C10—C11—C12	1.8 (2)
C2—C3—C15—O15	−176.13 (13)	C10—C11—C12—C7	0.6 (2)
C2—C3—C15—O16	4.74 (18)	C12—C7—C8—C9	1.2 (2)
C2—C7—C8—C9	−177.94 (12)	C14—O13—C10—C9	−177.18 (14)
C2—C7—C12—C11	177.04 (12)	C14—O13—C10—C11	2.0 (2)
C3—C2—C7—C8	64.43 (16)	C15—O16—C17—C18	179.91 (11)
C3—C2—C7—C12	−114.69 (14)	C15—C3—C4—N19	−2.5 (2)
C3—C4—C5—O5	−178.84 (13)	C15—C3—C4—C5	178.51 (12)
C3—C4—C5—N1	0.30 (14)	C17—O16—C15—O15	1.01 (19)
C4—N19—C20—C21	−74.66 (17)	C17—O16—C15—C3	−179.84 (10)
C4—C3—C15—O15	4.7 (2)	C20—N19—C4—C3	173.28 (13)
C4—C3—C15—O16	−174.48 (12)	C20—N19—C4—C5	−7.8 (2)
C5—N1—C2—C3	−0.80 (14)

Open in a new tab

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate . Hydrogen-bond geometry (Å, º)

D—H···A	D—H	H···A	D···A	D—H···A
N19—H19···O15	0.92 (1)	2.19 (2)	2.8595 (15)	129 (2)
O22—H22A···O15ⁱ	0.98 (1)	2.08 (2)	3.0131 (16)	157 (4)
O22—H22B···O22ⁱ	0.98 (2)	1.83 (2)	2.796 (2)	167 (4)
C6—H6B···O22ⁱⁱ	0.98	2.57	3.4152 (18)	144
C8—H8···O13ⁱⁱⁱ	0.95	2.34	3.2556 (17)	162

Open in a new tab

Symmetry codes: (i) −x+1, −y, −z+1; (ii) x, y+1, z; (iii) −x+3/2, y−1/2, −z+1/2.

References

Abdul Rashid, F. N. A., Bacho, M. Z., Slawin, A. M., Abdul Manan, M. A. F., Johari, S. A. & Mohammat, M. F. (2023). Z. Kristallogr. New Cryst. Struct.238, 113–115.
Chen, X. M., Lu, W., Zhang, Z. H., Zhang, J. Y., Tuong, T. M. L., Liu, L. L., Kim, Y. H., Li, C. H. & Gao, J. M. (2022). Phytochemistry, 196, 113082. [DOI] [PubMed]
Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst.42, 339–341.
Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst.53, 226–235. [DOI] [PMC free article] [PubMed]
Metten, B., Kostermans, M., Van Baelen, G., Smet, M. & Dehaen, W. (2006). Tetrahedron, 62, 6018–6028.
Miranda, A. C., Barbosa, L. C., Masood, M. A., Varejão, J. O. S., Sordi, M., Benfatti, C. A. & Pimenta, A. L. (2018). ACS Omega, 3, 18475–18480.
Ōmura, S. & Crump, A. (2019). J. Antibiot.72, 189–201. [DOI] [PMC free article] [PubMed]
Rashid, F. N. A. A., Mohammat, M. F., Bouchamma, F. E., Shaameri, Z. & Hamzah, A. S. (2020). Russ. J. Org. Chem.56, 1082–1088.
Rigaku OD (2024). CrysAlis PRO. Rigaku Corporation, Tokyo, Japan.
Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
Wang, C., Wu, X., Bai, H., Zaman, K. A. U., Hou, S., Saito, J., Wongwiwatthananukit, S., Kim, K. S. & Cao, S. (2020). J. Nat. Prod.83, 2233–2240. [DOI] [PubMed]
Westrip, S. P. (2010). J. Appl. Cryst.43, 920–925.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2414314624012227/hb4500sup1.cif

x-09-x241222-sup1.cif^{(1.7MB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2414314624012227/hb4500Isup2.hkl

x-09-x241222-Isup2.hkl^{(266.4KB, hkl)}

x-09-x241222-Isup3.cml^{(6.2KB, cml)}

Supporting information file. DOI: 10.1107/S2414314624012227/hb4500Isup3.cml

CCDC reference: 2411088

Additional supporting information: crystallographic information; 3D view; checkCIF report

[bb1] Abdul Rashid, F. N. A., Bacho, M. Z., Slawin, A. M., Abdul Manan, M. A. F., Johari, S. A. & Mohammat, M. F. (2023). Z. Kristallogr. New Cryst. Struct.238, 113–115.

[bb2] Chen, X. M., Lu, W., Zhang, Z. H., Zhang, J. Y., Tuong, T. M. L., Liu, L. L., Kim, Y. H., Li, C. H. & Gao, J. M. (2022). Phytochemistry, 196, 113082. [DOI] [PubMed]

[bb3] Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst.42, 339–341.

[bb4] Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst.53, 226–235. [DOI] [PMC free article] [PubMed]

[bb5] Metten, B., Kostermans, M., Van Baelen, G., Smet, M. & Dehaen, W. (2006). Tetrahedron, 62, 6018–6028.

[bb6] Miranda, A. C., Barbosa, L. C., Masood, M. A., Varejão, J. O. S., Sordi, M., Benfatti, C. A. & Pimenta, A. L. (2018). ACS Omega, 3, 18475–18480.

[bb7] Ōmura, S. & Crump, A. (2019). J. Antibiot.72, 189–201. [DOI] [PMC free article] [PubMed]

[bb8] Rashid, F. N. A. A., Mohammat, M. F., Bouchamma, F. E., Shaameri, Z. & Hamzah, A. S. (2020). Russ. J. Org. Chem.56, 1082–1088.

[bb9] Rigaku OD (2024). CrysAlis PRO. Rigaku Corporation, Tokyo, Japan.

[bb10] Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.

[bb11] Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.

[bb12] Wang, C., Wu, X., Bai, H., Zaman, K. A. U., Hou, S., Saito, J., Wongwiwatthananukit, S., Kim, K. S. & Cao, S. (2020). J. Nat. Prod.83, 2233–2240. [DOI] [PubMed]

[bb13] Westrip, S. P. (2010). J. Appl. Cryst.43, 920–925.

PERMALINK

Ethyl 4-[(2-hydroxyethyl)amino]-2-(4-methoxyphenyl)-1-methyl-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylate

Fatin Nur Ain Abdul Rashid

Mohd Fazli Mohammat

Mohd Abdul Fatah Abdul Manan

Ayisy Amirul Afti Bakhtiar Afendy

David B Cordes

Aidan P McKay

Roles

Abstract

Structure description